On 10 February 2026, Zhong Ji Longevity Science Group Limited (Stock Code: 767) released an announcement outlining the composition of its board of directors. According to the document, the board consists of two executive directors, two non-executive directors, and four independent non-executive directors. The executive directors are Yan Li—who serves as both Chairman and Chief Executive Officer—and Li Xiaoshuang. The non-executive directors are He Yiwu and Lyu Changsheng. The independent non-executive directors are Huang Jiang, Professor Huang Cibo, Wang Huijuan, and Tam Mei Chu.

The announcement also details five board committees. The Audit Committee is chaired by Huang Jiang, while the Nomination Committee, Risk Management Committee, and Share Award Committee are each led by Yan Li. The Remuneration Committee is again chaired by Huang Jiang. All committees include membership from the four independent non-executive directors, with Yan Li serving as Chair for the Nomination, Risk Management, and Share Award Committees.